Marizyme (Marizyme) Days Payable : 21,900.00 (As of Mar. 2024)

View and export this data going back to 2008. Start your Free Trial

What is Marizyme Days Payable?

Marizyme's average Accounts Payable for the three months ended in Mar. 2024 was $2.40 Mil. Marizyme's Cost of Goods Sold for the three months ended in Mar. 2024 was $0.01 Mil. Hence, Marizyme's Days Payable for the three months ended in Mar. 2024 was 21,900.00.

The historical rank and industry rank for Marizyme's Days Payable or its related term are showing as below:

MRZM' s Days Payable Range Over the Past 10 Years
Min: 478.28 Med: 1266.33 Max: 9094.58
Current: 4949.4

During the past 13 years, Marizyme's highest Days Payable was 9094.58. The lowest was 478.28. And the median was 1266.33.

MRZM's Days Payable is ranked better than
92.65% of 721 companies
in the Biotechnology industry
Industry Median: 148.78 vs MRZM: 4949.40

Marizyme's Days Payable increased from Mar. 2023 (3,624.26) to Mar. 2024 (21,900.00). It may suggest that Marizyme delayed paying its suppliers.

Marizyme Days Payable Historical Data

The historical data trend for Marizyme's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Marizyme Days Payable Chart

Marizyme Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

1,875.34

4,088.00

9,094.58

3,340.33

Marizyme Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Payable	Get a 7-Day Free Trial															3,624.26	3,568.79	3,734.99	4,053.18	21,900.00

Competitive Comparison of Marizyme's Days Payable

For the Biotechnology subindustry, Marizyme's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Marizyme's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Marizyme's Days Payable distribution charts can be found below:

* The bar in red indicates where Marizyme's Days Payable falls into.

Marizyme Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Marizyme's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (1.225	+	2.216)	/	2 )	/	0.188	*	365
=	1.7205					/	0.188	*	365
=	3,340.33

Marizyme's Days Payable for the quarter that ended in Mar. 2024 is calculated as:

	Days Payable (Q: Mar. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2023 )	+	Accounts Payable (Q: Mar. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Mar. 2024 )	*	Days in Period
=	( (2.216	+	2.584)	/	2 )	/	0.01	*	365 / 4
=	2.4					/	0.01	*	365 / 4
=	21,900.00

Marizyme Days Payable Related Terms

Thank you for viewing the detailed overview of Marizyme's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Marizyme (Marizyme) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Marizyme Inc (OTCPK:MRZM) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

555 Heritage Drive, Suite 205, Jupiter, FL, USA, 33458

Website

https://www.marizyme.com

Marizyme Inc is a multi-technology biomedical company dedicated to the accelerated development and commercialization of medical device technologies that improve patient health outcomes. Currently, the company is focused on developing three medical technology products: DuraGraft, Krillase, and MATLOC. DuraGraft is a single-use intraoperative vascular graft treatment that protects against ischemic injury and reduces the incidence and complications of graft failure, MATLOC is a point-of-care, lab-on-chip digital screening, and diagnostic device platform, initially being developed for quantitative chronic kidney disease, or CKD, assessment, and Krillase protein enzyme provides a therapeutics opportunity for wound healing, thrombosis, and pet health.

Executives

Braeden Lichti	10 percent owner	650 GEORGIA ST #3200, VANCOUVER A1 V6B4P7
Nilesh Umedbhai Patel	director	555 HERITAGE DRIVE, SUITE 205, JUPITER FL 33458
Michael R Stewart	director	5 WALNUT GROVE DRIVE, STE 140, HORSHAM PA 19044
Harrison Ross	officer: Vice President of Finance	555 HERITAGE DRIVE, SUITE 205, JUPITER FL 33458
Georgiy Kovalyov	officer: Chief Financial Officer	555 HERITAGE DRIVE, SUITE 205, JUPITER FL 33458
David Barthel	director, officer: Chief Executive Officer	555 HERITAGE DRIVE, SUITE 205, JUPITER FL 33458
Bradley Richmond	officer: Acting VP of Finance	555 HERITAGE DRIVE, SUITE 205, JUPITER FL 33458
Julie B. Kampf	director	14054 OLD CYPRESS BEND, PALM BEACH GARDENS FL 33410
Vithalbhai D Dhaduk	director	FNCB BANCORP, INC., 102 E. DRINKER ST., DUNMORE PA 18512
Neil J Campbell	director, officer: Chief Executive Officer	225 CHIMNEY CORNER LANE, SUITE 2001, JUPITER FL 33458
Very Donald Leroy Jr	officer: Executive Vice President	4 SILVERWHITE AVENUE, LITTLE SILVER NJ 07739
William Hearl	director	448 SALK CIRCLE, GAITHERSBERG MD 20878
Bruce Harmon	officer: Chief Financial Officer	316 DEL PRADO BLVD. S., SUITE 204, CAPE CORAL FL 33990
Catherine J. Pachuk	officer: Chief Science Officer	1033 N. JEAGA DR, JUPITER FL 33458
Satishchandran Chandrasekhar	officer: Chief Operating Officer	167 CARMELA COURT, JUPITER FL 33478